Market Research Logo

Teva Pharmaceutical Industries Limited (TEVA) - Financial and Strategic SWOT Analysis Review

Teva Pharmaceutical Industries Limited (TEVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description – A detailed description of the company’s operations and business divisions.
Corporate strategy – Analyst’s summarization of the company’s business strategy.
SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
Company history – Progression of key events associated with the company.
Major products and services – A list of major products, services and brands of the company.
Key competitors – A list of key competitors to the company.
Key employees – A list of the key executives of the company.
Executive biographies – A brief summary of the executives’ employment history.
Key operational heads – A list of personnel heading key departments/functions.
Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities – A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Teva Pharmaceutical Industries Ltd. ( (Teva) is a pharmaceutical company, which focuses on the development, manufacture and marketing of generics, branded pharmaceuticals and active pharmaceutical ingredients (APIs). It offers chemical and therapeutic equivalents of branded medicines in various forms such as capsules, tablets, ointments, liquids, creams, injectables and inhalants. The company offers specialty pharmaceuticals in central nervous system, respiratory, oncology, women’s health and selected other areas. Teva also provides over-the-counter (OTC) products through a joint venture with P&G primarily in Israel and Hungary. It has operations in the Americas, the Middle East and Africa, Europe and Asia-Pacific. Teva is headquartered in Tikva, Israel.

Teva Pharmaceutical Industries Limited Key Recent Developments

Feb 11, 2016: Teva Reports Full Year 2015 and Fourth Quarter Financial Results
Jan 25, 2016: Teva Releases Innovation and Social Responsibility Highlights
Nov 19, 2015: Teva and University College London Embark on Unique Brain Imaging Study Aimed at Unlocking a New Approach in Neurodegenerative Disease
Nov 02, 2015: Teva’s Statement on its Internal Specialty Pharmacy
Oct 29, 2015: Teva Reports Third Quarter 2015 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Teva Pharmaceutical Industries Limited - Key Facts
Teva Pharmaceutical Industries Limited - Key Employees
Teva Pharmaceutical Industries Limited - Key Employee Biographies
Teva Pharmaceutical Industries Limited - Major Products and Services
Teva Pharmaceutical Industries Limited - Pharmaceutical Pipeline Products Data
Teva Pharmaceutical Industries Limited, Pipeline Products by Therapy Area
Teva Pharmaceutical Industries Limited, Pipeline Products by Development Phase
Teva Pharmaceutical Industries Limited - Medical Equipment Pipeline Products Data
Teva Pharmaceutical Industries Limited Pipeline Products by Equipment Type
Teva Pharmaceutical Industries Limited Pipeline Products by Development Stage
Teva Pharmaceutical Industries Limited - History
Teva Pharmaceutical Industries Limited - Company Statement
Teva Pharmaceutical Industries Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Teva Pharmaceutical Industries Limited - Business Description
Teva Pharmaceutical Industries Limited - Corporate Strategy
Teva Pharmaceutical Industries Limited - SWOT Analysis
SWOT Analysis - Overview
Teva Pharmaceutical Industries Limited - Strengths
Strength - Strong Presence - Central Nervous System Market
Strength - Dominant Market Position
Strength - Emphasis on Research and Development Activities
Teva Pharmaceutical Industries Limited - Weaknesses
Weakness - Declining Profitability
Weakness - Safety Issues/Product Defects
Teva Pharmaceutical Industries Limited - Opportunities
Opportunity - Inorganic Growth: Acquisitions
Opportunity - Product Launches in US Market
Opportunity - Strategic Partnerships
Teva Pharmaceutical Industries Limited - Threats
Threat - Industry Regulations
Threat - Competitive Pressures
Threat - Uncertain R&D Outcomes
Teva Pharmaceutical Industries Limited - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Teva Pharmaceutical Industries Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Teva Pharmaceutical Industries Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Teva Pharmaceutical Industries Limited, Medical Equipment, Deals By Year, 2010 to YTD 2016
Teva Pharmaceutical Industries Limited, Medical Equipment, Deals By Type, 2010 to YTD 2016
Teva Pharmaceutical Industries Limited, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 11, 2016: Teva Reports Full Year 2015 and Fourth Quarter Financial Results
Jan 25, 2016: Teva Releases Innovation and Social Responsibility Highlights
Nov 19, 2015: Teva and University College London Embark on Unique Brain Imaging Study Aimed at Unlocking a New Approach in Neurodegenerative Disease
Nov 02, 2015: Teva’s Statement on its Internal Specialty Pharmacy
Oct 29, 2015: Teva Reports Third Quarter 2015 Results
Sep 10, 2015: Teva Pharmaceuticals and IBM Partner to Build Global e-Health Solutions on the IBM Watson Health Cloud
Sep 08, 2015: Teva Introduces “Design for Dialogue” to Support Patient-Doctor Conversations on Responsible Pain Management
Jul 30, 2015: Teva Reports Strong Second Quarter 2015 Results and Raises Guidance for Full-Year 2015
Jul 27, 2015: Teva Reports Preliminary Second Quarter 2015 Results
May 18, 2015: R&D alliance restructure presents new DNA damage response partnership opportunities including leading PolQ project
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Teva Pharmaceutical Industries Limited, Key Facts
Teva Pharmaceutical Industries Limited, Key Employees
Teva Pharmaceutical Industries Limited, Key Employee Biographies
Teva Pharmaceutical Industries Limited, Major Products and Services
Teva Pharmaceutical Industries Limited, Number of Pipeline Products by Therapy Area
Teva Pharmaceutical Industries Limited, Number of Pipeline Products by Development Stage
Teva Pharmaceutical Industries Limited, Pipeline Products By Therapy Area and Development Phase
Teva Pharmaceutical Industries Limited Number of Pipeline Products by Equipment Type
Teva Pharmaceutical Industries Limited Pipeline Products by Equipment Type
Teva Pharmaceutical Industries Limited Number of Pipeline Products by Development Stage
Teva Pharmaceutical Industries Limited Pipeline Products by Development Stage
Teva Pharmaceutical Industries Limited, History
Teva Pharmaceutical Industries Limited, Other Locations
Teva Pharmaceutical Industries Limited, Subsidiaries
Teva Pharmaceutical Industries Limited, Joint Venture
Teva Pharmaceutical Industries Limited, Key Competitors
Teva Pharmaceutical Industries Limited, Ratios based on current share price
Teva Pharmaceutical Industries Limited, Annual Ratios
Teva Pharmaceutical Industries Limited, Interim Ratios
Teva Pharmaceutical Industries Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Teva Pharmaceutical Industries Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Teva Pharmaceutical Industries Limited, Medical Equipment, Deals By Year, 2010 to YTD 2016
Teva Pharmaceutical Industries Limited, Medical Equipment, Deals By Type, 2010 to YTD 2016
Teva Pharmaceutical Industries Limited, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Teva Pharmaceutical Industries Limited, Pipeline Products by Therapy Area
Teva Pharmaceutical Industries Limited, Pipeline Products by Development Phase
Teva Pharmaceutical Industries Limited Pipeline Products by Equipment Type
Teva Pharmaceutical Industries Limited Pipeline Products by Development Stage
Teva Pharmaceutical Industries Limited, Performance Chart (2010 - 2014)
Teva Pharmaceutical Industries Limited, Ratio Charts
Teva Pharmaceutical Industries Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Teva Pharmaceutical Industries Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Teva Pharmaceutical Industries Limited, Medical Equipment, Deals By Year, 2010 to YTD 2016
Teva Pharmaceutical Industries Limited, Medical Equipment, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report